Identification of human presequence protease (hPreP) agonists for the treatment of Alzheimer's disease

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy et al. · Advanced Drug Delivery Reviews · 1997 · 11.2K citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94

Thomas A. Halgren · Journal of Computational Chemistry · 1996 · 5.3K citations

Natural Sciences, Biophysics, Computational Chemistry +12

ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease

Joyce W. Lustbader, Maurizio Cirilli, Chang Lin et al. · Science · 2004 · 1.3K citations

Life Sciences, Biochemistry, Neuroscience +17

Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression

Maria Mańczak, Thimmappa S. Anekonda, Edward Henson et al. · Human Molecular Genetics · 2006 · 1.1K citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease

Jia Yao, Ronald W. Irwin, Liqin Zhao et al. · Proceedings of the National Academy of Sciences · 2009 · 933 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17